Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124492832 | 12449283 | 2 | F | 201511 | 20160704 | 20160608 | 20160711 | EXP | US-ASTRAZENECA-2016SE60516 | ASTRAZENECA | 11.00 | MON | F | Y | 6.40000 | KG | 20160712 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124492832 | 12449283 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 3 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 4 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 5 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 6 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 7 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 8 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 9 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 10 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 11 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 12 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 13 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 14 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 15 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | U | U | 0 | 100 | MG | INJECTION | ||||||
| 124492832 | 12449283 | 16 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | 160 MG | 0 | |||||||||||
| 124492832 | 12449283 | 17 | C | VIGANTOLETTEN | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 124492832 | 12449283 | 18 | C | SALBUTAMOL | ALBUTEROL | 1 | 0 | ||||||||||||
| 124492832 | 12449283 | 19 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 124492832 | 12449283 | 20 | C | M-M-R II | MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGENMUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGENRUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124492832 | 12449283 | 1 | Premature baby |
| 124492832 | 12449283 | 2 | Antiviral prophylaxis |
| 124492832 | 12449283 | 3 | Hydrocephalus |
| 124492832 | 12449283 | 4 | Premature baby |
| 124492832 | 12449283 | 5 | Antiviral prophylaxis |
| 124492832 | 12449283 | 6 | Hydrocephalus |
| 124492832 | 12449283 | 7 | Premature baby |
| 124492832 | 12449283 | 8 | Antiviral prophylaxis |
| 124492832 | 12449283 | 9 | Hydrocephalus |
| 124492832 | 12449283 | 10 | Premature baby |
| 124492832 | 12449283 | 11 | Antiviral prophylaxis |
| 124492832 | 12449283 | 12 | Hydrocephalus |
| 124492832 | 12449283 | 13 | Premature baby |
| 124492832 | 12449283 | 14 | Antiviral prophylaxis |
| 124492832 | 12449283 | 15 | Hydrocephalus |
| 124492832 | 12449283 | 16 | Product used for unknown indication |
| 124492832 | 12449283 | 17 | Product used for unknown indication |
| 124492832 | 12449283 | 18 | Product used for unknown indication |
| 124492832 | 12449283 | 19 | Product used for unknown indication |
| 124492832 | 12449283 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124492832 | 12449283 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124492832 | 12449283 | Bronchial hyperreactivity | |
| 124492832 | 12449283 | General physical health deterioration | |
| 124492832 | 12449283 | Pneumonia respiratory syncytial viral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124492832 | 12449283 | 1 | 20151008 | 20151008 | 0 | |
| 124492832 | 12449283 | 2 | 20151008 | 20151008 | 0 | |
| 124492832 | 12449283 | 3 | 20151008 | 20151008 | 0 | |
| 124492832 | 12449283 | 4 | 20151111 | 20151111 | 0 | |
| 124492832 | 12449283 | 5 | 20151111 | 20151111 | 0 | |
| 124492832 | 12449283 | 6 | 20151111 | 20151111 | 0 | |
| 124492832 | 12449283 | 7 | 20151218 | 20151218 | 0 | |
| 124492832 | 12449283 | 8 | 20151218 | 20151218 | 0 | |
| 124492832 | 12449283 | 9 | 20151218 | 20151218 | 0 | |
| 124492832 | 12449283 | 10 | 20160118 | 20160118 | 0 | |
| 124492832 | 12449283 | 11 | 20160118 | 20160118 | 0 | |
| 124492832 | 12449283 | 12 | 20160118 | 20160118 | 0 | |
| 124492832 | 12449283 | 13 | 20160412 | 20160412 | 0 | |
| 124492832 | 12449283 | 14 | 20160412 | 20160412 | 0 | |
| 124492832 | 12449283 | 15 | 20160412 | 20160412 | 0 | |
| 124492832 | 12449283 | 16 | 20150921 | 0 | ||
| 124492832 | 12449283 | 20 | 20160211 | 20160211 | 0 |